Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012 (2012), Article ID 872978, 11 pages
http://dx.doi.org/10.1155/2012/872978
Review Article

Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy

1Department of Endocrinology, Hospital Vall d’Hebron, Barcelona, Spain
2Diabetes and Metabolism Research Unit, Vall d'Hebron Institute of Research (VHIR), Autonomous University of Barcelona, Pg Vall d'Hebron 119-129, 08035 Barcelona, Spain
3CIBER de Diabetes y Enfermedades Metabólicas Asociadas, (CIBERDEM), Instituto de Salud Carlos III, 08035 Barcelona, Spain

Received 18 July 2012; Accepted 21 August 2012

Academic Editor: Ahmed M. Abu El-Asrar

Copyright © 2012 Olga Simó-Servat et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” The Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Chen, M. Looman, M. Laouri et al., “Burden of illness of diabetic macular edema: literature review,” Current Medical Research and Opinion, vol. 26, no. 7, pp. 1587–1597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. E. L. Lamoureux and T. Y. Wong, “Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials,” Diabetes Care, vol. 34, no. 4, pp. 1066–1067, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. J. C. Javitt, “Cost savings associated with detection and treatment of diabetic eye disease,” PharmacoEconomics, vol. 8, supplement 1, pp. 33–39, 1995. View at Google Scholar · View at Scopus
  5. E. M. Pelletier, B. Shim, R. Ben-Joseph, and J. J. Caro, “Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis,” PharmacoEconomics, vol. 27, no. 6, pp. 479–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Heintz, A. B. Wirehn, B. B. Peebo, U. Rosenqvist, and L. Å. Levin, “Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden,” Diabetologia, vol. 53, no. 10, pp. 2147–2154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Mohamed, M. C. Gillies, and T. Y. Wong, “Management of diabetic retinopathy: a systematic review,” JAMA, vol. 298, no. 8, pp. 902–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Simó and C. Hernández, “Advances in the medical treatment of diabetic retinopathy,” Diabetes Care, vol. 32, no. 8, pp. 1556–1562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Simó and C. Hernández, “Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy,” Diabetologia, vol. 51, no. 9, pp. 1574–1580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Robinson, V. A. Barathi, S. S. Chaurasia, T. Y. Wong, and T. S. Kern, “Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals,” DMM Disease Models and Mechanisms, vol. 5, no. 4, pp. 444–456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Ambati, K. V. Chalam, D. K. Chawala et al., “Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 115, no. 9, pp. 1161–1166, 1997. View at Google Scholar · View at Scopus
  12. R. Simó, E. Carrasco, M. García-Ramírez, and C. Hernández, “Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy,” Current Diabetes Reviews, vol. 2, no. 1, pp. 71–98, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Simó and C. Hernández, “Growth factors in the diabetic eye,” Frontiers in Diabetes, vol. 20, pp. 109–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Carrasco, C. Hernández, A. Miralles, P. Huguet, J. Farrés, and R. Simó, “Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration,” Diabetes Care, vol. 30, no. 11, pp. 2902–2908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Garcia-Ramírez, C. Hernández, M. Villarroel et al., “Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy,” Diabetologia, vol. 52, no. 12, pp. 2633–2641, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Antonetti, R. Klwin, and T. W. Gardner, “Diabetic retinopathy,” The New England Journal of Medicine, vol. 13, pp. 1227–1239, 2012. View at Google Scholar
  17. T. S. Kern, “Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy,” Experimental Diabetes Research, vol. 2007, p. 95103, 2007. View at Google Scholar · View at Scopus
  18. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Abu el-Asrar, “Role of inflammation in the pathogenesis of Diabetic Retinopathy,” Middle East African Journal of Ophthalmology, vol. 19, pp. 70–74, 2012. View at Google Scholar
  20. G. Guarda and A. So, “Regulation of inflammasome activity,” Immunology, vol. 130, no. 3, pp. 329–336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. R. A. Kowluru and S. Odenbach, “Role of interleukin-1β in the pathogenesis of diabetic retinopathy,” British Journal of Ophthalmology, vol. 88, no. 10, pp. 1343–1347, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Ludwig, O. Strunk, R. Westram et al., “ARB: a software environment for sequence data,” Nucleic Acids Research, vol. 32, no. 4, pp. 1363–1371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Vincent and S. Mohr, “Inhibition of caspase-1/interleukin-1β signaling prevents degeneration of retinal capillaries in diabetes and galactosemia,” Diabetes, vol. 56, no. 1, pp. 224–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Demircan, B. G. Safran, M. Soylu, A. A. Ozcan, and S. Sizmaz, “Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy,” Eye, vol. 20, no. 12, pp. 1366–1369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. I. Patel, G. M. Saleh, P. G. Hykin, Z. J. Gregor, and I. A. Cree, “Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy,” Eye, vol. 22, no. 2, pp. 223–228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Posada, “jModelTest: phylogenetic model averaging,” Molecular Biology and Evolution, vol. 25, no. 7, pp. 1253–1256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Hernández, R. M. Segura, A. Fonollosa, E. Carrasco, G. Francisco, and R. Simó, “Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy,” Diabetic Medicine, vol. 22, no. 6, pp. 719–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Hayasaka, X. Y. Zhang, H. S. Cui et al., “Vitreous chemokines and Sho (Zheng in Chinese) of Chinese-Korean-Japanese medicine in patients with diabetic vitreoretinopathy,” American Journal of Chinese Medicine, vol. 34, no. 4, pp. 537–543, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Murugeswari, D. Shukla, A. Rajendran, R. Kim, P. Namperumalsamy, and V. Muthukkaruppan, “Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease,” Retina, vol. 28, no. 6, pp. 817–824, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. D. Taub, M. Anver, J. J. Oppenheim, D. L. Longo, and W. J. Murphy, “T lymphocyte recruitment by interleukin-8 (IL-8): IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo,” The Journal of Clinical Investigation, vol. 97, no. 8, pp. 1931–1941, 1996. View at Google Scholar · View at Scopus
  31. H. Ghasemi, T. Ghazanfari, R. Yaraee, S. Faghihzadeh, and Z. M. Hassan, “Roles of IL-8 in ocular inflammations: a review,” Ocular Immunology and Inflammation, vol. 19, no. 6, pp. 401–412, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. I. A. El-Ghrably, H. S. Dua, G. M. Orr, D. Fischer, and P. J. Tighe, “Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy,” British Journal of Ophthalmology, vol. 85, no. 4, pp. 461–470, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. A. M. Abu El-Asrar, S. Struyf, D. Kangave, K. Geboes, and J. Van Damme, “Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy,” European Cytokine Network, vol. 17, no. 3, pp. 155–165, 2006. View at Google Scholar · View at Scopus
  34. W. Zhang, H. Liu, M. Al-Shabrawey, R. Caldwell, and R. Caldwell, “Inflammation and diabetic retinal microvascular complications,” Journal of Cardiovascular Disease Research, vol. 2, no. 2, pp. 96–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Gharaee-Kermani, E. M. Denholm, and S. H. Phan, “Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors,” The Journal of Biological Chemistry, vol. 271, no. 30, pp. 17779–17784, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. K. H. Hong, J. Ryu, and K. H. Han, “Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A,” Blood, vol. 105, no. 4, pp. 1405–1407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Rangasamy, P. G. McGuire, and A. Das, “Diabetic retinopathy and inflammation: novel therapeutic targets,” Middle East African Journal of Ophthalmology, vol. 19, no. 1, pp. 52–59, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S. G. Elner, R. Strieter, Z. M. Bian et al., “Interferon-induced protein 10 and interleukin 8: C-X-C chemokines present in proliferative diabetic retinopathy,” Archives of Ophthalmology, vol. 116, no. 12, pp. 1597–1601, 1998. View at Google Scholar · View at Scopus
  39. Y. Suzuki, M. Nakazawa, K. Suzuki, H. Yamazaki, and Y. Miyagawa, “Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion,” Japanese Journal of Ophthalmology, vol. 55, no. 3, pp. 256–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. R. M. Strieter, M. D. Burdick, J. Mestas, B. Gomperts, M. P. Keane, and J. A. Belperio, “Cancer CXC chemokine networks and tumour angiogenesis,” European Journal of Cancer, vol. 42, no. 6, pp. 768–778, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Godessart and S. L. Kunkel, “Chemokines in autoimmune disease,” Current Opinion in Immunology, vol. 13, no. 6, pp. 670–675, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Lasagni, M. Francalanci, F. Annunziato et al., “An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4,” Journal of Experimental Medicine, vol. 197, no. 11, pp. 1537–1549, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. S. G. Kelsen, M. O. Aksoy, Y. Yang et al., “The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells,” American Journal of Physiology, vol. 287, no. 3, pp. L584–L591, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. R. J. Bodnar, C. C. Yates, and A. Wells, “IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain,” Circulation Research, vol. 98, no. 5, pp. 617–625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Shiraha, A. Glading, J. Chou, Z. Jia, and A. Wells, “Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain,” Molecular and Cellular Biology, vol. 22, no. 8, pp. 2716–2727, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Petrai, K. Rombouts, L. Lasagni et al., “Activation of p38MAPK mediates the angiostatic effect of the chemokine receptor CXCR3-B,” International Journal of Biochemistry and Cell Biology, vol. 40, no. 9, pp. 1764–1774, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. R. J. Bodnar, C. C. Yates, M. E. Rodgers, X. Du, and A. Wells, “IP-10 induces dissociation of newly formed blood vessels,” Journal of Cell Science, vol. 122, no. 12, part 2, pp. 2064–2077, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. L. Angiolillo, C. Sgadari, D. D. Taub et al., “Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo,” Journal of Experimental Medicine, vol. 182, no. 1, pp. 155–162, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. R. M. Strieter, S. L. Kunkel, D. A. Arenberg, M. D. Burdick, and P. J. Polverini, “Interferon γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis,” Biochemical and Biophysical Research Communications, vol. 210, no. 1, pp. 51–57, 1995. View at Publisher · View at Google Scholar · View at Scopus
  50. C. C. Yates-Binder, M. Rodgers, J. Jaynes, A. Wells, R. J. Bodnar, and T. Turner, “An IP-10 (CXCL10)-derived peptide inhibits angiogenesis,” PLoS ONE, vol. 7, no. 7, Article ID e40812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. H. M. Hatch, D. Zheng, M. L. Jorgensen, and B. E. Petersen, “SDF-1α/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats,” Cloning and Stem Cells, vol. 4, no. 4, pp. 339–351, 2002. View at Google Scholar · View at Scopus
  52. J. M. Butler, S. M. Guthrie, M. Koc et al., “SDF-1 is both necessary and sufficient to promote proliferative retinopathy,” The Journal of Clinical Investigation, vol. 115, no. 1, pp. 86–93, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. M. B. Grant, A. Afzal, P. Spoerri, H. Pan, L. C. Shaw, and R. N. Mames, “The role of growth factors in the pathogenesis of diabetic retinopathy,” Expert Opinion on Investigational Drugs, vol. 13, no. 10, pp. 1275–1293, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. A. El-Asrar, M. I. Nawaz, D. Kangave et al., “High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy,” Molecular Vision, vol. 17, pp. 1829–1838, 2011. View at Google Scholar · View at Scopus
  55. N. Parameswaran and S. Patial, “Tumor necrosis factor-a signaling in macrophages,” Critical Reviews in Eukaryotic Gene Expression, vol. 20, no. 2, pp. 87–103, 2010. View at Google Scholar · View at Scopus
  56. S. E. Kahn, R. L. Hull, and K. M. Utzschneider, “Mechanisms linking obesity to insulin resistance and type 2 diabetes,” Nature, vol. 444, no. 7121, pp. 840–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Doganay, C. Evereklioglu, H. Er et al., “Comparison of serum NO, TNF-α, IL-1β, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus,” Eye, vol. 16, no. 2, pp. 163–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. C. A. Aveleira, C. M. Lin, S. F. Abcouwer, A. F. Ambrósio, and D. A. Antonetti, “TNF-α signals through PKCζ/NF-κB to alter the tight junction complex and increase retinal endothelial cell permeability,” Diabetes, vol. 59, no. 11, pp. 2872–2882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Kitaoka, Y. Kitaoka, J. M. K. Kwong et al., “TNF-α-induced optic nerve degeneration and nuclear factor-κB p65,” Investigative Ophthalmology and Visual Science, vol. 47, no. 4, pp. 1448–1457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. M. G. Madigan, A. A. Sadun, N. S. Rao, P. U. Dugel, W. N. Tenhula, and P. S. Gill, “Tumor necrosis factor-alpha (TNF-α)-induced optic neuropathy in rabbits,” Neurological Research, vol. 18, no. 2, pp. 176–184, 1996. View at Google Scholar · View at Scopus
  61. A. M. Joussen, V. Poulaki, N. Mitsiades et al., “Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression,” The FASEB Journal, vol. 16, no. 3, pp. 438–440, 2002. View at Google Scholar · View at Scopus
  62. A. Mirshahi, R. Hoehn, K. Lorenz, C. Kramann, and H. Baatz, “Anti-tumor necrosis factor alpha for retinal diseases: current knowledge and future concepts,” Journal of Ophthalmic and Vision Research, vol. 7, no. 1, pp. 39–44, 2012. View at Google Scholar
  63. A. M. Joussen, T. Murata, A. Tsujikawa, B. Kirchhof, S. E. Bursell, and A. P. Adamis, “Leukocyte-mediated endothelial cell injury and death in the diabetic retina,” American Journal of Pathology, vol. 158, no. 1, pp. 147–152, 2001. View at Google Scholar · View at Scopus
  64. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Tamura, K. Miyamoto, J. Kiryu et al., “Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina,” Investigative Ophthalmology and Visual Science, vol. 46, no. 4, pp. 1440–1444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. A. M. Joussen, V. Poulaki, N. Mitsiades et al., “Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes,” The FASEB Journal, vol. 17, no. 1, pp. 76–78, 2003. View at Google Scholar · View at Scopus
  67. D. S. McLeod, D. J. Lefer, C. Merges, and G. A. Lutty, “Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid,” American Journal of Pathology, vol. 147, no. 3, pp. 642–653, 1995. View at Google Scholar · View at Scopus
  68. H. Song, L. Wang, and Y. Hui, “Expression of CD18 on the neutrophils of patients with diabetic retinopathy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 1, pp. 24–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Kociok, S. Radetzky, T. U. Krohne et al., “ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization,” Experimental Eye Research, vol. 89, no. 4, pp. 503–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. G. A. Limb, J. Hickman-Casey, R. D. Hollifield, and A. H. Chignell, “Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 40, no. 10, pp. 2453–2457, 1999. View at Google Scholar · View at Scopus
  71. C. Hernández, R. Burgos, A. Cantón, J. García-Arumí, R. M. Segura, and R. Simó, “Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study,” Diabetes Care, vol. 24, no. 3, pp. 516–521, 2001. View at Google Scholar · View at Scopus
  72. J. Adamiec-Mroczek, J. Oficjalska-Młyńczak, and M. Misiuk-Hojło, “Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: analysis of vitreous samples,” Cytokine, vol. 49, no. 3, pp. 269–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Murata, K. Noda, J. Fukuhara et al., “Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 53, pp. 4055–4062, 2012. View at Google Scholar
  74. K. Noda, S. Nakao, S. Ishida et al., “Leukocyte adhesion molecules in diabetic retinopathy,” Journal of Ophthalmology, vol. 2012, Article ID 279037, 6 pages, 2012. View at Publisher · View at Google Scholar
  75. D. Navaratna, P. G. McGuire, G. Menicucci, and A. Das, “Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes,” Diabetes, vol. 56, no. 9, pp. 2380–2387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Cantón, E. M. Martinez-Cáceres, C. Hernández, C. Espejo, J. García-Arumí, and R. Simó, “CD4-CD8 and CD28 expression in T cells infiltrating the vitreous fluid in patients with proliferative diabetic retinopathy. A flow cytometric analysis,” Archives of Ophthalmology, vol. 122, no. 5, pp. 743–749, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Moalem, R. Leibowitz-Amit, E. Yoles, F. Mor, I. R. Cohen, and M. Schwartz, “Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy,” Nature Medicine, vol. 5, no. 1, pp. 49–55, 1999. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Schwartz, “T cell mediated neuroprotection is a physiological response to central nervous system insults,” Journal of Molecular Medicine, vol. 78, no. 11, pp. 594–597, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. G. Moalem, A. Gdalyahu, Y. Shani et al., “Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity,” Journal of Autoimmunity, vol. 15, no. 3, pp. 331–345, 2000. View at Publisher · View at Google Scholar · View at Scopus
  80. S. A. Wolf, J. Fisher, I. Bechmann, B. Steiner, E. Kwidzinski, and R. Nitsch, “Neuroprotection by T-cells depends on their subtype and activation state,” Journal of Neuroimmunology, vol. 133, no. 1-2, pp. 72–80, 2002. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Hernández, F. Ortega, M. García-Ramírez et al., “Lipopolysaccharide-binding protein and soluble CD14 in the vitreous fluid of patients with proliferative diabetic retinopathy,” Retina, vol. 30, no. 2, pp. 345–352, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. T. Nakanishi, R. Koyama, T. Ikeda, and A. Shimizu, “Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole,” Journal of Chromatography B, vol. 776, no. 1, pp. 89–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  83. R. Koyama, T. Nakanishi, T. Ikeda, and A. Shimizu, “Catalogue of soluble proteins in human vitreous humor by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry including seven angiogenesis-regulating factors,” Journal of Chromatography B, vol. 792, no. 1, pp. 5–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Yamane, A. Minamoto, H. Yamashita et al., “Proteome analysis of human vitreous proteins,” Molecular & Cellular Proteomics, vol. 2, no. 11, pp. 1177–1187, 2003. View at Google Scholar · View at Scopus
  85. C. W. Wu, J. L. Sauter, P. K. Johnson, C. D. Chen, and T. W. Olsen, “Identification and localization of major soluble vitreous proteins in human ocular tissue,” American Journal of Ophthalmology, vol. 137, no. 4, pp. 655–661, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. M. García-Ramírez, F. Canals, C. Hernández et al., “Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy,” Diabetologia, vol. 50, no. 6, pp. 1294–1303, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. T. Kim, J. K. Sang, K. Kim et al., “Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients,” Proteomics, vol. 7, no. 22, pp. 4203–4215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. B. B. Gao, X. Chen, N. Timothy, L. P. Aiello, and E. P. Feener, “Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy,” Journal of Proteome Research, vol. 7, no. 6, pp. 2516–2525, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Shitama, H. Hayashi, S. Noge et al., “Proteome profiling of vitreoretinal diseases by cluster analysis,” Proteomics–Clinical Applications, vol. 2, no. 9, pp. 1265–1280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Ouchi, K. West, J. W. Crabb, S. Kinoshita, and M. Kamei, “Proteomic analysis of vitreous from diabetic macular edema,” Experimental Eye Research, vol. 81, no. 2, pp. 176–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. B. B. Gao, A. Clermont, S. Rook et al., “Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation,” Nature Medicine, vol. 13, no. 2, pp. 181–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Hernández, M. García-Ramírez, N. Colomé et al., “New pathogenic candidates for diabetic macular edema detected by proteomic analysis,” Diabetes Care, vol. 33, no. 7, p. e92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. W. Chen, H. Lu, K. Dutt, A. Smith, D. Hunt Margaret, and R. C. Hunt, “Expression of the protective proteins hemopexin and haptoglobin cells of the neural retina,” Experimental Eye Research, vol. 67, no. 1, pp. 83–93, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. J. J. Kapojos, A. Van Den Berg, H. Van Goor et al., “Production of hemopexin by TNF-α stimulated human mesangial cells,” Kidney International, vol. 63, no. 5, pp. 1681–1686, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. A. S. Wilson, B. G. Hobbs, W. Y. Shen et al., “Argon laser photocoagulation-induced modification of gene expression in the retina,” Investigative Ophthalmology and Visual Science, vol. 44, no. 4, pp. 1426–1434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” The New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994. View at Publisher · View at Google Scholar · View at Scopus
  97. R. Simó, A. Lecube, L. Sararols et al., “Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients. Possible role in the development of proliferative diabetic retinopathy,” Diabetes Care, vol. 25, no. 12, pp. 2282–2286, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Simó, E. Carrasco, A. Fonollosa, J. García-Arumí, R. Casamitjana, and C. Hernández, “Deficit of somatostatin in the vitreous fluid of patients with diabetic macular edema,” Diabetes Care, vol. 30, no. 3, pp. 725–727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Hernández, E. Carrasco, R. Casamitjana, R. Deulofeu, J. García-Arumí, and R. Simó, “Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects,” Diabetes Care, vol. 28, no. 8, pp. 1941–1947, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. C. Hernández and R. Simó, “Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice,” Expert Opinion on Investigational Drugs, vol. 16, no. 8, pp. 1209–1226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. I. Barba, M. Garcia-Ramírez, C. Hernández et al., “Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor,” Investigative Ophthalmology and Visual Science, vol. 51, no. 9, pp. 4416–4421, 2010. View at Publisher · View at Google Scholar · View at Scopus